Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595491 · ClinicalTrials.gov registry record · Phase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
A Phase 1 study of Asthma, sponsored by Benjamin Medoff.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 313
- Enrollment target
- 1
- Study location
NCT00595491: Recruiting Phase 1 study of Asthma, sponsored by Benjamin Medoff.
NCT00595491 is a Phase 1 study of Asthma that is actively recruiting participants, run by Benjamin Medoff. The registered enrollment target is 313 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595491, a Phase 1 study of Asthma, is actively recruiting participants, sponsored by Benjamin Medoff.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 313 participants
- Enrollment target
- 1
- Study location
Study Summary
Asthma is a heterogeneous disorder in which multiple potential inflammatory pathways contribute to airway obstruction. The biological basis for airway inflammation is the subject of intensive investigation. This work is designed to identify airway factors that are responsible for recruiting cells and associate their airway presence with atopy and asthma.
Conditions Studied
Interventions
- BIOLOGICAL Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 313 participants |
| Start Date | 2008-01 |
| Est. Completion | 2029-01-31 |
| Phase | Phase 1 |
What NCT00595491 shows while recruiting
NCT00595491 is an interventional study that assigns participants to a tested intervention. The registered 313 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage is the first listed.
NCT00595491 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00595491 about?
NCT00595491 is a clinical study titled "Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation". Asthma is a heterogeneous disorder in which multiple potential inflammatory pathways contribute to airway obstruction. The biological basis for airway inflammation is the subject of intensive investigation. This work is designed to identify airway factors that are responsible for recruiting cells an...
What is the current status of trial NCT00595491?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 313 participants. The study started on 2008-01. Estimated completion is 2029-01-31.
What conditions does trial NCT00595491 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00595491?
The interventions under investigation include: Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage (BIOLOGICAL).
Who is sponsoring clinical trial NCT00595491?
This trial is sponsored by Benjamin Medoff, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00595491 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00595491's enrollment target sits among peer trials
313 120th of 374 higher than 255 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
RECRUITING · Phase 1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
ACTIVE NOT RECRUITING · Phase 1
-
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
- NCT06883097 · 314 participants · NA
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia